Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Introduction to the Special Issue on Clinical and Public Health Genomics: Opportunities for translational behavioral medicine research, practice, and policy.

Literature DB >> 29385593

Introduction to the Special Issue on Clinical and Public Health Genomics: Opportunities for translational behavioral medicine research, practice, and policy.

Kristi D Graves¹, Michael J Hall², Kenneth P Tercyak¹.

Abstract

Mesh：

Year: 2018 PMID： 29385593 PMCID： PMC6065537 DOI： 10.1093/tbm/ibx068

Source DB: PubMed Journal: Transl Behav Med ISSN： 1613-9860 Impact factor: 3.046

× No keyword cloud information.

21 in total

1. Shared decision making: Implications for return of results from whole-exome and whole-genome sequencing.

Authors: Susan T Vadaparampil; Deborah Cragun
Journal: Transl Behav Med Date: 2018-01-29 Impact factor: 3.046

Review 2. Communication of cancer-related genetic and genomic information: A landscape analysis of reviews.

Authors: Emily B Peterson; Wen-Ying Sylvia Chou; Anna Gaysynsky; Melinda Krakow; Ashley Elrick; Muin J Khoury; Kimberly A Kaphingst
Journal: Transl Behav Med Date: 2018-01-29 Impact factor: 3.046

3. Translation research to apply genomics to improve health promotion: Is it worth the investment?

Authors: Colleen M McBride
Journal: Transl Behav Med Date: 2018-01-29 Impact factor: 3.046

4. Parental attitudes and expectations towards receiving genomic test results in healthy children.

Authors: Alanna Kulchak Rahm; Lindsay Bailey; Kara Fultz; Audrey Fan; Janet L Williams; Adam Buchanan; F Daniel Davis; Michael F Murray; Marc S Williams
Journal: Transl Behav Med Date: 2018-01-29 Impact factor: 3.046

5. Factors influencing the impact of pharmacogenomic prescribing on adherence to nicotine replacement therapy: A qualitative study of participants from a randomized controlled trial.

Authors: Alison J Wright; Stephen Sutton; David Armstrong; Paul Aveyard; Ann Louise Kinmonth; Theresa M Marteau
Journal: Transl Behav Med Date: 2018-01-29 Impact factor: 3.046

6. A comparison of views regarding the use of de-identified data.

Authors: Deborah Goodman; Catherine O Johnson; Deborah Bowen; Megan Smith; Lari Wenzel; Karen L Edwards
Journal: Transl Behav Med Date: 2018-01-29 Impact factor: 3.046

7. Preferences for learning different types of genome sequencing results among young breast cancer patients: Role of psychological and clinical factors.

Authors: Kimberly A Kaphingst; Jennifer Ivanovich; Sarah Lyons; Barbara Biesecker; Rebecca Dresser; Ashley Elrick; Cindy Matsen; Melody Goodman
Journal: Transl Behav Med Date: 2018-01-29 Impact factor: 3.046

2. Introduction to the diamond anniversary special issue: systematic reviews in Translational Behavioral Medicine and an editorial look ahead.

Authors: Suzanne M Miller; Keith M Bellizzi; Deborah J Bowen; Michael A Diefenbach; Kenneth P Tercyak
Journal: Transl Behav Med Date: 2020-10-12 Impact factor: 3.046

2 in total

Introduction to the Special Issue on Clinical and Public Health Genomics: Opportunities for translational behavioral medicine research, practice, and policy.

1. Shared decision making: Implications for return of results from whole-exome and whole-genome sequencing.

Review 2. Communication of cancer-related genetic and genomic information: A landscape analysis of reviews.

3. Translation research to apply genomics to improve health promotion: Is it worth the investment?

4. Parental attitudes and expectations towards receiving genomic test results in healthy children.

5. Factors influencing the impact of pharmacogenomic prescribing on adherence to nicotine replacement therapy: A qualitative study of participants from a randomized controlled trial.

6. A comparison of views regarding the use of de-identified data.

7. Preferences for learning different types of genome sequencing results among young breast cancer patients: Role of psychological and clinical factors.

8. Genetic test reporting of CDKN2A provides informational and motivational benefits for managing melanoma risk.

9. Effect of co-payment on behavioral response to consumer genomic testing.

10. No Shortcuts on the Long Road to Evidence-Based Genomic Medicine.

1. A primer in genomics for social and behavioral investigators.

2. Introduction to the diamond anniversary special issue: systematic reviews in Translational Behavioral Medicine and an editorial look ahead.